Ferrer: Verge Genomics, Ferrer enter collaboration to codevelop clinicalstage ALS therapy VRG50635
Verge Genomics, a leading clinical─stage biotechnology company, and Ferrer, an international B Corp pharmaceutical company with an increasing focus in rare neurological disorders, have announced a strategic collaboration to co─develop VRG50635
Read full article »
Ferrer is a fully vertically integrated pharmaceutical firm from research and development, through manufacturing, to sales and distribution.
Read more